Second generation BTK inhibitors impair the anti-fungal response of macrophages and neutrophils

Am J Hematol. 2020 Jul;95(7):E174-E178. doi: 10.1002/ajh.25816. Epub 2020 Apr 29.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Agammaglobulinaemia Tyrosine Kinase / antagonists & inhibitors*
  • Agammaglobulinaemia Tyrosine Kinase / immunology
  • Aspergillus fumigatus / immunology*
  • Candida albicans / immunology*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell / immunology*
  • Macrophages / immunology*
  • Macrophages / pathology
  • Neoplasm Proteins / antagonists & inhibitors*
  • Neoplasm Proteins / immunology
  • Neutrophils / immunology*
  • Neutrophils / pathology
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / adverse effects*

Substances

  • Neoplasm Proteins
  • Protein Kinase Inhibitors
  • Agammaglobulinaemia Tyrosine Kinase
  • BTK protein, human